Philipp Albrecht
@albrecht5.bsky.social
PhD student in gastrointestinal oncology @dkfz.bsky.social
Likes organoids, bioinformatics, public outreach and sustainability. 🧬🥼
Likes organoids, bioinformatics, public outreach and sustainability. 🧬🥼
💻 Multi-omics analyses and large-scale drug testing in patient-derived in vitro models may expand the repertoire of identified tumor sensitivities and thereby contribute to improved patient survival. 📈
June 24, 2025 at 9:34 AM
💻 Multi-omics analyses and large-scale drug testing in patient-derived in vitro models may expand the repertoire of identified tumor sensitivities and thereby contribute to improved patient survival. 📈
We summarise currently approved chemo- and immunotherapies, e.g., the recent approval of zolbetuximab for CLDN18.2+ tumors 🎯
@oncoalert.bsky.social
@oncoalert.bsky.social
June 24, 2025 at 9:34 AM
We summarise currently approved chemo- and immunotherapies, e.g., the recent approval of zolbetuximab for CLDN18.2+ tumors 🎯
@oncoalert.bsky.social
@oncoalert.bsky.social
Fortunately, I was cleared to donate! 🥳
A few weeks later, I donated stem cells and they were sent off to the US. 🛫🇺🇸
A few weeks later, I donated stem cells and they were sent off to the US. 🛫🇺🇸
December 4, 2024 at 12:25 PM
Fortunately, I was cleared to donate! 🥳
A few weeks later, I donated stem cells and they were sent off to the US. 🛫🇺🇸
A few weeks later, I donated stem cells and they were sent off to the US. 🛫🇺🇸
@dkfz.bsky.social sunsets never disappoint 🌅
November 28, 2024 at 9:04 PM
@dkfz.bsky.social sunsets never disappoint 🌅